Regional Stocks
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Celgene Corp (NQ: CELG)
123.64 USD  +0.20 (+0.16%)
Official Closing Price  /  Updated: 8:10 PM EDT, May 23, 2013  /  Add to My Watchlist      
View: Quote News Research
Press releases about Celgene Corp
 
< Previous 1 2
...
15 16 17 18 19 20 21 22 Next >
ISS Recommends Pharmion Shareholders Vote for Merger With Celgene
February 26, 2008
All Four Leading Independent Proxy Advisory Firms Recommend Pharmion stockholders vote FOR merger with Celgene Read More
from PR Newswire
Wall Street News Alert: ELHI, Thursday's Hot Stock to Watch! February 14, 2008
February 14, 2008
NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by Wall Street Capital Funding. Read More
from Marketwired News Releases
Seven Summits Research Releases Alerts on JNJ, BIDU, CAT, CELG, and SFD
February 13, 2008
from PR Newswire
Featured Stocks on Today's Edition of The Analyst's Review: DNA, CELG, GILD, ALNY, REGN
February 12, 2008
An all-new interview with Scott Sand, CEO of Ingen Technologies, Inc. is also available on WallSt.net Read More
from PR Newswire
Celgene Corporation to Present at Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
February 04, 2008
from Business Wire News Releases
Clinical Data Reported on Celgene Compound Apremilast (CC-10004) Evaluating Efficacy, Safety and Quality of Life Improvement for Psoriasis Patients
February 04, 2008
Updated results presented at 66th American Academy of Dermatology Meeting Read More
from Business Wire News Releases
Celgene Reports Record Fourth Quarter and Full Year 2007 Product Sales and Operating Profits
January 31, 2008
from Business Wire News Releases
Amsterdam Molecular Therapeutics to Appoint Philippe van Holle (Celgene) to Supervisory Board
January 31, 2008
from PR Newswire
Celgene Corporation to Present at Wachovia Healthcare Conference
January 28, 2008
from Business Wire News Releases
Zacks Earnings Preview: Celgene, Occidental Petroleum, Petro-Canada, VMware and YRC Worldwide
January 28, 2008
from Business Wire News Releases
German Federal Cartel Office Clears Celgene to Acquire Pharmion
January 28, 2008
from Business Wire News Releases
Celgene Corporation to Announce Fourth Quarter and Year-End 2007 Results on January 31, 2008
January 25, 2008
from Business Wire News Releases
Featured Stocks on Today's Edition of The Analyst's Review: DNA, AMGN, BIIB, CELG, MLNM, BMRN
January 18, 2008
from PR Newswire
Celgene Selects SupplyScape's Product Security Software to Strengthen Patient Safety Initiatives
January 11, 2008
Industry's Most Widely Adopted Electronic Pedigree and EPC Product Authentication Solution to Help Celgene Increase Supply Chain Integrity Read More
from Business Wire News Releases
Beacon Research Issues TraderNotes on XSNX, NOEC, PYTO, CELG, AERO
January 07, 2008
from PR Newswire
Seven Summits Research Releases Comments on BBY, CELG, SLM, CROX, and MHS
January 07, 2008
from PR Newswire
REPEAT/Celgene Corporation Reviews 2007 Achievements and Announces 2008 Financial Outlook
January 07, 2008
from Business Wire News Releases
Celgene Corporation Reviews 2007 Achievements and Announces 2008 Financial Outlook
January 06, 2008
from Business Wire News Releases
Celgene/Pharmion Hart-Scott-Rodino (HSR) Thirty Day Waiting Period Expires
January 03, 2008
from Business Wire News Releases
Seven Summits Research Releases Alerts on AMAT, RIG, CELG, CVS, and SOLF
December 21, 2007
from PR Newswire
Celgene Will Provide Fourth Quarter and Full-Year 2007 Guidance at the 26th Annual JP Morgan Healthcare Conference
December 20, 2007
Company will provide full-year 2008 guidance Read More
from Business Wire News Releases
Monmouth Medical Center, in Partnership with LifebankUSA(R), Launches Program for Placental and Cord Blood Stem Cell Banking
December 12, 2007
from Business Wire News Releases
Pre-Market Stock Report: EXPT! December 11, 2007
December 11, 2007
NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by Stock Market Alerts. Read More
from Marketwired News Releases
Seven Summits Research Releases Alerts on TXN, PBR, WFC, ISRG, and CELG
December 10, 2007
from PR Newswire
113 Abstracts Evaluating Celgene Products to Be Presented at the 49th American Society of Hematology Meeting
December 05, 2007
Sixty-five Abstracts Investigating REVLIMID(R) in a Broad Range of Hematological Cancers Read More
from Business Wire News Releases
Celgene Corporation to Present at BMO Capital Markets Focus on Healthcare Conference
November 30, 2007
from Business Wire News Releases
Updated REVLIMID(R) (Lenalidomide) Plus Dexamethasone Data in Previously Treated Multiple Myeloma Reported in The New England Journal of Medicine
November 21, 2007
Major Phase III Studies Report Oral REVLIMID Plus Dexamethasone Shows Time to Disease Progression and Overall Survival in Patients with Relapsed or Refractory Multiple Myeloma Read More
from Business Wire News Releases
Celgene Corporation to Present at Lazard Healthcare Conference
November 21, 2007
from Business Wire News Releases
Celgene Corporation to Present at Piper Jaffray Healthcare Conference
November 20, 2007
from Business Wire News Releases
Stocks in Focus on Today's Edition of 'Before the Bell:' LOW, CELG, CPB.
November 20, 2007
An in-depth interview with the CEO of Noveko International, Inc. is also available at http://www.wallst.net Read More
from PR Newswire
< Previous 1 2
...
15 16 17 18 19 20 21 22 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here